Dexamethasone and supportive care with or without whole brain radiotherapy in treating patients with non-small cell lung cancer with brain metastases unsuitable for resection or stereotactic radiotherapy (QUARTZ): results from a phase 3, non-inferiority, randomised trial

BACKGROUND: Whole brain radiotherapy (WBRT) and dexamethasone are widely used to treat brain metastases from non-small cell lung cancer (NSCLC), although there have been no randomised clinical trials showing that WBRT improves either quality of life or overall survival. Even after treatment with WBR...

Descripción completa

Detalles Bibliográficos
Autores principales: Mulvenna, Paula, Nankivell, Matthew, Barton, Rachael, Faivre-Finn, Corinne, Wilson, Paula, McColl, Elaine, Moore, Barbara, Brisbane, Iona, Ardron, David, Holt, Tanya, Morgan, Sally, Lee, Caroline, Waite, Kathryn, Bayman, Neil, Pugh, Cheryl, Sydes, Benjamin, Stephens, Richard, Parmar, Mahesh K, Langley, Ruth E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2016
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5082599/
https://www.ncbi.nlm.nih.gov/pubmed/27604504
http://dx.doi.org/10.1016/S0140-6736(16)30825-X

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5082599/
https://www.ncbi.nlm.nih.gov/pubmed/27604504
http://dx.doi.org/10.1016/S0140-6736(16)30825-X

Ejemplares similares